Rasagiline Tablet
Product Images NDC 42571-221

3 FDA label images from Micro Labs Limited · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Rasagiline (NDC 42571-221). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Micro Labs Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Rasagiline Structure)

Structure (Rasagiline Structure)
Chemical structure of Rasagiline mesylate, the active ingredient in RASAGILINE tablets. The structure shows a bicyclic system attached to an amino group and a propargyl side chain, with an associated mesylate (CH3SO3H) component.*
FDA Label Image

Rasagiline-lbla.jpg (Rasagiline Lbla)

Rasagiline-lbla.jpg (Rasagiline Lbla)
Rasagiline Tablets 0.5 mg label showing 30 tablets per package. The label includes storage instructions and dosage reference, with manufacturer Micro Labs Limited in India and Micro Labs USA, Inc. in Somerset, NJ noted. The NDC code is 42571-220-30 and the revision date is 05/2025.*
FDA Label Image

Rasagiline-lblb.jpg (Rasagiline Lblb)

Rasagiline-lblb.jpg (Rasagiline Lblb)
Label for Rasagiline Tablets 1 mg oral tablets by Micro Labs Limited. The package contains 30 tablets and is Rx only. The label states each tablet contains rasagiline mesylate equivalent to 1 mg rasagiline. Storage instructions specify controlled room temperature. Manufactured in India for Micro Labs USA, Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.